Covid-19, caused by infection with SARS-CoV-2, has resulted in the most serious pandemic in over a century.  The response to the pandemic has also witnessed an unprecedented output of scientific studies on Covid and SARS-CoV-2 and the extraordinary achievements of the discovery, manufacture, rigorous clinical assessment and roll-out of numerous therapeutics including multiple vaccines, small molecule and biologic therapeutics.  To frame a better understanding of the clinical impact, molecular mechanisms and disease control regarding these advances, Expert Reviews in Molecular Medicine will host a special collection on Covid-19.  We welcome submissions critically evaluating the literature on SARS-COV-2 pathogenesis, immunity and Covid therapeutics including but not limited to:

• Molecular mechanisms of monoclonal antibody neutralization of SARS-CoV-2

• A review of mRNA-based vaccine platforms

• Covid-19 therapeutics: from molecules to mode of action

• Structure-informed vaccine design with an emphasis on SARS-CoV-2

• An overview of the molecular immune response to SARS-CoV-2

• An evaluation of innate and/or adaptive immunity to SARS-CoV-2 and relationship to disease

• Interaction between COVID-19 and other diseases

We invite authors to submit reviews (see instructions to authors) via Editorial Manager.  We welcome authors to reach out to the Special Collection Editors with an abstract and brief outline to discuss suitability of the proposed review.

Guest Editors: 

Professor Babak Javid (University of California, USA) contactable at: bjavid@gmail.com

Dr Lei Huang (University of Newcastle, UK) contactable at: Lei.Huang@newcastle.ac.uk 

Dr Péter Bay (University of Debrecen, Hungary) contactable at: baip@med.unideb.hu